'Boreali v. Axelrod': The Limits of Agency Power

In his Health Law column, Francis J. Serbaroli, a shareholder at Greenberg Traurig, re-visits the New York Court of Appeals landmark 'Boreali v. Axelrod' decision on its 25th anniversary and finds the decision remains an important warning to executive branch agencies not to infringe upon the legislature's prerogatives.

This article requires premium access

This article requires premium access to The New York Law Journal. Please sign in or subscribe to read the full text.